| GILEAD SCIENCES DL-,001 |
| USA |
| Gesundheit |
| US3755581036 / 885823 |
| GIS (Frankfurt) / GILD (NASDAQ) |
| FRA:GIS, ETR:GIS, GIS:GR, NASDAQ:GILD |
| https://www.gilead.com/ |
|
Gilead Sciences Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious and life-threatening diseases. Its current business centers on virology, oncology, and inflammation, with a particularly..
>Volltext.. |
| 189630.77 Mio. EUR |
| 205714.77 Mio. EUR |
| 27830.54 Mio. EUR |
| - |
| -3461.35 Mio. EUR |
| -2.78 EUR |
| - |
| - |
| 12973.55 Mio. EUR |
| 0.54 |
| 10.74% |
| -149.34% |
| 2.8 EUR |
| 1.9% |
| 1.9% |
| 15.09.26 - 0.710366€ 15.06.26 - 0.707578€ >weitere anzeigen... |
| 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.827.702 Euro. |
| GILEAD, REMDESIVIR |
| 01.11.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|